Topical Antibiotics and Intravitreous Injections

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Christopher Ta, Stanford University
ClinicalTrials.gov Identifier:
NCT00410891
First received: October 2, 2006
Last updated: June 28, 2013
Last verified: June 2013

October 2, 2006
June 28, 2013
July 2008
December 2009   (final data collection date for primary outcome measure)
conjunctival bacterial flora [ Time Frame: 3 days ] [ Designated as safety issue: No ]
number of bacteria on the conjunctiva
Not Provided
Complete list of historical versions of study NCT00410891 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Topical Antibiotics and Intravitreous Injections
Not Provided

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
  • Intravitreous
  • Injections
Drug: gatifloxacin
Experimental: topical antibiotic
topical gatifloxacin 4 times per day
Intervention: Drug: gatifloxacin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
129
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • intravitreous injection

Exclusion Criteria:

  • antibiotic use
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00410891
96803 (eProtocol 4384
Not Provided
Christopher Ta, Stanford University
Stanford University
Not Provided
Principal Investigator: Christopher Ta, MD Stanford University
Stanford University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP